Whitehawk Therapeutics, Inc.
WHWK
$1.57
$0.031.95%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -63.69M | -61.69M | -65.44M | -68.83M | -65.77M |
| Total Depreciation and Amortization | 193.00K | 190.00K | 187.00K | 181.00K | 169.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.00M | 10.99M | 11.22M | 10.96M | 9.34M |
| Change in Net Operating Assets | -6.05M | -3.63M | 3.63M | -319.00K | -3.40M |
| Cash from Operations | -59.55M | -54.14M | -50.41M | -58.01M | -59.66M |
| Capital Expenditure | -1.65M | -2.28M | -3.19M | -3.34M | -3.97M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 26.86M | 18.00M | 26.49M | 80.77M | 87.18M |
| Cash from Investing | 25.20M | 15.72M | 23.30M | 77.43M | 83.21M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 146.00K | 208.00K | 210.00K | 478.00K | 486.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -16.00K | -51.00K | -128.00K | -170.00K | -160.00K |
| Cash from Financing | 130.00K | 157.00K | 82.00K | 308.00K | 326.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -34.22M | -38.27M | -27.02M | 19.73M | 23.87M |